These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22718320)

  • 21. New developments in the medical treatment of endometriosis.
    Bedaiwy MA; Alfaraj S; Yong P; Casper R
    Fertil Steril; 2017 Mar; 107(3):555-565. PubMed ID: 28139238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.
    Machado DE; Berardo PT; Landgraf RG; Fernandes PD; Palmero C; Alves LM; Abrao MS; Nasciutti LE
    Fertil Steril; 2010 May; 93(8):2674-9. PubMed ID: 20056215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins as Targeted "Magical Pills" for the Conservative Treatment of Endometriosis: May Potential Adverse Effects on Female Fertility Represent the "Dark Side of the Same Coin"? A Systematic Review of Literature.
    Vitagliano A; Noventa M; Quaranta M; Gizzo S
    Reprod Sci; 2016 Apr; 23(4):415-28. PubMed ID: 25929256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?
    Bayoglu Tekin Y; Guven S; Kirbas A; Kalkan Y; Tumkaya L; Guvendag Guven ES
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():1-6. PubMed ID: 25462211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoxin A4 inhibits the development of endometriosis in mice: the role of anti-inflammation and anti-angiogenesis.
    Xu Z; Zhao F; Lin F; Chen J; Huang Y
    Am J Reprod Immunol; 2012 Jun; 67(6):491-7. PubMed ID: 22229383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiangiogenic therapies in endometriosis.
    Ferrero S; Ragni N; Remorgida V
    Br J Pharmacol; 2006 Sep; 149(2):133-5. PubMed ID: 16894342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
    Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
    Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical Management of Endometriosis in Patients with Chronic Pelvic Pain.
    Bedaiwy MA; Allaire C; Yong P; Alfaraj S
    Semin Reprod Med; 2017 Jan; 35(1):38-53. PubMed ID: 28002850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: an in vitro model of endometriosis.
    Canosa S; Moggio A; Brossa A; Pittatore G; Marchino GL; Leoncini S; Benedetto C; Revelli A; Bussolati B
    Mol Hum Reprod; 2017 Mar; 23(3):187-198. PubMed ID: 28158750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future targets in endometriosis treatment: targeting the endometriotic implant.
    Nothnick WB; Zhang X
    Mini Rev Med Chem; 2009 Mar; 9(3):324-8. PubMed ID: 19275725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
    Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
    Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of novel fumagillin and ovalicin analogues.
    Mazitschek R; Huwe A; Giannis A
    Org Biomol Chem; 2005 Jun; 3(11):2150-4. PubMed ID: 15917904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant human endostatin on endometriosis in mice.
    Jiang HQ; Li YL; Zou J
    Chin Med J (Engl); 2007 Jul; 120(14):1241-6. PubMed ID: 17697575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical management of endometriosis: a systematic review.
    Schroder AK; Diedrich K; Ludwig M
    IDrugs; 2004 May; 7(5):451-63. PubMed ID: 15154107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility.
    Abbas MA; Taha MO; Zihlif MA; Disi AM
    Eur J Pharmacol; 2013 Feb; 702(1-3):12-9. PubMed ID: 23353590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions.
    Thanatsis N; Filindris T; Siampalis A; Papageorgiou E; Panagodimou E; Adonakis G; Kaponis A
    Obstet Gynecol Surv; 2021 May; 76(5):281-291. PubMed ID: 34032860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasculogenesis: a new piece of the endometriosis puzzle.
    Laschke MW; Giebels C; Menger MD
    Hum Reprod Update; 2011; 17(5):628-36. PubMed ID: 21586449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects.
    Tapdıgova R; Bayrak G; Yılmaz BC; Aytan H
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):673-680. PubMed ID: 35294604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunomodulatory therapy for severe influenza.
    Darwish I; Mubareka S; Liles WC
    Expert Rev Anti Infect Ther; 2011 Jul; 9(7):807-22. PubMed ID: 21810053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plant-derived medicines for treatment of endometriosis: A comprehensive review of molecular mechanisms.
    Bina F; Soleymani S; Toliat T; Hajimahmoodi M; Tabarrai M; Abdollahi M; Rahimi R
    Pharmacol Res; 2019 Jan; 139():76-90. PubMed ID: 30412733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.